E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/21/2011 in the Prospect News Fund Daily and Prospect News Structured Products Daily.

New Issue: RBS prices initial $4 million of 0% RBS Global Big Pharma ETNs due 2041

By Marisa Wong

Madison, Wis., Oct. 21 - Royal Bank of Scotland plc plans to issue from time to time up to $100 million of 0% RBS Global Big Pharma exchange-traded notes due Oct. 25, 2041 linked to the NYSE Arca Equal Weighted Pharmaceutical Total Return index, according to a 424B5 filing with the Securities and Exchange Commission. The issuer priced an initial $4 million of the exchange-traded notes on Oct. 21.

The index is comprised of equity securities of a cross-section of companies involved in various phases of development, production and marketing of pharmaceuticals.

The daily redemption value of each note is $25 at inception. For each day after that, the daily redemption value is equal to (a) the daily redemption value on the preceding day times (b) the index factor on that day times (c) the daily fee factor.

The index factor on any valuation date is equal to the index closing level on that day divided by the index closing level on the preceding day.

The daily fee factor is equal to (a) one minus (b) (i) an investor fee of 0.6% per year times (ii) the number of days from the preceding valuation date to the current valuation day divided by (iii) 365.

The payout at maturity will be the daily redemption value of the ETNs on Oct. 22, 2041.

The notes are putable at any time, subject to a minimum of 20,000 ETNs, and are callable in whole at any time. The redemption amount will equal the daily redemption value on the relevant valuation date, which will be three business days before the repurchase date.

The notes will be automatically accelerated if the daily redemption value ever equals zero.

The ETNs will be listed on NYSE Arca under the ticker symbol "DRGS."

RBS Securities Inc. is the underwriter.

Issuer:Royal Bank of Scotland plc
Issue:RBS Global Big Pharma ETNs
Amount:$4 million
Maturity:Oct. 25, 2041
Coupon:0%
Price:Par of $25
Payout at maturity:Daily redemption value on Oct. 22, 2041; daily redemption value is (a) daily redemption value on preceding day times (b) index factor times (c) fee factor based on investor fee of 0.6% per year; index factor on any day is index closing level on that day divided by index closing level on preceding day
Put option:At any time, minimum of 20,000 ETNs; redemption amount determined in same manner as payout at maturity
Call option:In whole at any time; redemption amount determined in same manner as payout at maturity
Pricing date:Oct. 21
Settlement date:Oct. 26
Underwriter:RBS Securities Inc.
Fees:None
Cusip:78009P135
Listing:NYSE Arca: DRGS

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.